Felbamate (Felbamate)
Overview of Felbamate
Felbamate is a carbamate structurally related meprobamate. Felbamate is used in the treatment of epilepsy. Felbamate is used alone or in combination with other agents for refractory partial seizures with or without secondary generalisation.
Indication of Felbamate
Indications
Contraindication of Felbamate
Felbamate is contraindicated in conditions like Blood dyscrasias,Bone marrow depression,Hepatic dysfunction,Hypersensitivity.
Side Effects of Felbamate
The severe or irreversible adverse effects of Felbamate, which give rise to further complications include Stevens johnson syndrome, Stevens johnson syndrome.,Felbamate produces potentially life-threatening effects which include Aplastic Anemia, Hepatic failure, Aplastic anemia. which are responsible for the discontinuation of Felbamate therapy.,The signs and symptoms that are produced after the acute overdosage of Felbamate include Impaired breathly, Gastric distress, Increased heart rate.,The symptomatic adverse reactions produced by Felbamate are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Headache, Nausea, Vomiting, Anorexia, Insomnia, Somnolence, Hypokalemia, Hypophosphatemia, dizziness.
Precautions of Felbamate
Complete blood counts and liver function tests should be carried out before the patient starts treatment and regularly during tretament. The drug should be discontinued if there is any evidence of bone marrow deppressio or liver abnormalities. Take protective measures against exposure to UV radiation because drug may cause photosensitivity reaction. Also with renal impairment.